{
  "ticker": "LLY",
  "target_date": "2024-12-13",
  "actual_date": "2024-12-13",
  "collected_at": "2025-12-08T11:08:50.590759",
  "price": {
    "open": 771.38,
    "high": 788.37,
    "low": 767.27,
    "close": 783.2776489257812,
    "volume": 3059400,
    "change_1d_pct": 0.87,
    "change_7d_pct": -4.91,
    "change_30d_pct": -4.74
  },
  "technicals": {
    "rsi_14": 64.63,
    "sma_20": 776.62,
    "sma_50": 828.33,
    "macd": -6.426,
    "macd_signal": -9.508,
    "macd_histogram": 3.082,
    "bb_upper": 840.26,
    "bb_lower": 712.98,
    "price_vs_sma20_pct": 0.86,
    "price_vs_sma50_pct": -5.44,
    "volume_ratio": 0.74
  },
  "fundamentals": {
    "market_cap": 891651751936,
    "pe_ratio": 48.732975,
    "forward_pe": 43.89409,
    "price_to_book": 37.448795,
    "price_to_sales": 15.00597,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.55,
    "pct_from_52w_low": 59.45
  },
  "macro": {
    "spy": {
      "price": 596.95,
      "change_1d_pct": -0.02,
      "change_7d_pct": -0.4
    },
    "vix": {
      "level": 13.81,
      "signal": "LOW_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.4
    },
    "dollar_index": {
      "level": 107.0
    },
    "gold": {
      "price": 2656.0
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value",
      "source": "SeekingAlpha",
      "datetime": 1734134056,
      "summary": "Learn how to maximize returns by focusing on high-conviction stocks across diverse sectors and using proven investment strategies.",
      "url": "https://finnhub.io/api/news?id=55d1529df95faa211f30c69c3af5c9bc27914aaccba3736ed4c24b15134a2681"
    },
    {
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of December 15",
      "source": "SeekingAlpha",
      "datetime": 1734126012,
      "summary": "Stay updated on dividend activity for top companies, including changes in dividends and upcoming ex-dividend and pay dates.",
      "url": "https://finnhub.io/api/news?id=33fc43392efd9cfd584d56169da5b7754635c9c7d87d7a9f028ac564d6f5e124"
    },
    {
      "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "source": "MarketWatch",
      "datetime": 1734107580,
      "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=f65e593ac7d3875954c3b4e753c98c5f088944f6e797141a2f189806a5e711ef"
    },
    {
      "headline": "Ozempic Works on Kidney Disease, Regulator Says. Why Novo Nordisk Stock Is Falling.",
      "source": "Yahoo",
      "datetime": 1734102180,
      "summary": "Novo Nordisk's Ozempic will become the first and only GLP-1 drug to be shown to reduce progression of kidney disease in adults with Type 2 diabetes.",
      "url": "https://finnhub.io/api/news?id=4f29d1705e9cc01e48299551e1b0219ecf3f31d8527bf8d8ddbb6a25d79e376d"
    },
    {
      "headline": "Lilly's Omvoh\u00ae (mirikizumab) recommended by CHMP for approval in the European Union for adults with moderately to severely active Crohn's disease",
      "source": "Yahoo",
      "datetime": 1734095460,
      "summary": "Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Omvoh\u00ae (mirikizumab), an interleukin-23p19 (IL-23p19) antagonist, for the treatment of adults with moderately to severe",
      "url": "https://finnhub.io/api/news?id=75da4bee091ba5c1b7e58921367fee4c4eaa7786982c278c5b9305cba796c834"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2024-11-20",
      "description": "xslF345X05/wk-form4_1732138184.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000278/xslF345X05/wk-form4_1732138184.xml"
    },
    {
      "form": "4",
      "date": "2024-11-20",
      "description": "xslF345X05/wk-form4_1732138122.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000276/xslF345X05/wk-form4_1732138122.xml"
    },
    {
      "form": "4",
      "date": "2024-11-20",
      "description": "xslF345X05/wk-form4_1732138066.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000274/xslF345X05/wk-form4_1732138066.xml"
    },
    {
      "form": "4",
      "date": "2024-11-20",
      "description": "xslF345X05/wk-form4_1732138010.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000272/xslF345X05/wk-form4_1732138010.xml"
    },
    {
      "form": "4",
      "date": "2024-11-20",
      "description": "xslF345X05/wk-form4_1732137954.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000270/xslF345X05/wk-form4_1732137954.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}